Vykat Xr
Payments companies reported to CMS as associated with Vykat Xr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vykat Xr, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vykat Xr
These are the largest totals companies reported as associated with Vykat Xr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Parisa Salehi | Fairbanks, AK | Pediatric Endocrinology | $50,752.49 |
| Jennifer Miller | Gainesville, FL | Pediatric Endocrinology | $45,223.26 |
| Jorge Mejia-Corletto | North Babylon, NY | Pediatric Endocrinology | $41,991.32 |
| Ashley Shoemaker | Nashville, TN | Pediatric Endocrinology | $20,000.00 |
| Bradley Miller | Minneapolis, MN | Pediatric Endocrinology | $10,854.99 |
| Deepan Singh | Glen Oaks, NY | Psychiatry | $10,792.96 |
| Olga Gupta | Durham, NC | Pediatric Endocrinology | $10,357.32 |
| Scott Clements | Salt Lake City, UT | Pediatric Endocrinology | $9,450.86 |
| Doris Estrada | Washington, DC | Pediatric Endocrinology | $8,993.03 |
| Eric Felner | Atlanta, GA | Pediatric Endocrinology | $8,184.54 |
Prescribed Vykat Xr?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.